# Special Drug Use Surveillance for Entresto Tablets

> **NCT04781881** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 688 (actual)

## Conditions studied

- Chronic Heart Failure

## Interventions

- **DRUG:** Entresto

## Key facts

- **NCT ID:** NCT04781881
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-04
- **Primary completion:** 2023-04-21
- **Final completion:** 2023-04-21
- **Target enrollment:** 688 (ACTUAL)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04781881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04781881, "Special Drug Use Surveillance for Entresto Tablets". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04781881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*